Atea Pharmaceuticals Statistics
Total Valuation
AVIR has a market cap or net worth of $257.00 million. The enterprise value is -$202.49 million.
Important Dates
The last earnings date was Thursday, March 6, 2025, after market close.
Earnings Date | Mar 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AVIR has 85.53 million shares outstanding. The number of shares has increased by 1.05% in one year.
Current Share Class | 85.53M |
Shares Outstanding | 85.53M |
Shares Change (YoY) | +1.05% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | 13.21% |
Owned by Institutions (%) | 59.15% |
Float | 66.62M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.56 |
P/TBV Ratio | 0.57 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.85, with a Debt / Equity ratio of 0.00.
Current Ratio | 24.85 |
Quick Ratio | 24.44 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.88% and return on invested capital (ROIC) is -16.56%.
Return on Equity (ROE) | -33.88% |
Return on Assets (ROA) | -15.60% |
Return on Invested Capital (ROIC) | -16.56% |
Return on Capital Employed (ROCE) | -29.64% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.01M |
Employee Count | 56 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, AVIR has paid $925,000 in taxes.
Income Tax | 925,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.49% in the last 52 weeks. The beta is 0.18, so AVIR's price volatility has been lower than the market average.
Beta (5Y) | 0.18 |
52-Week Price Change | -26.49% |
50-Day Moving Average | 3.08 |
200-Day Moving Average | 3.37 |
Relative Strength Index (RSI) | 41.73 |
Average Volume (20 Days) | 263,320 |
Short Selling Information
The latest short interest is 2.91 million, so 3.41% of the outstanding shares have been sold short.
Short Interest | 2.91M |
Short Previous Month | 2.87M |
Short % of Shares Out | 3.41% |
Short % of Float | 4.38% |
Short Ratio (days to cover) | 10.02 |
Income Statement
Revenue | n/a |
Gross Profit | -83.37M |
Operating Income | -132.22M |
Pretax Income | -174.95M |
Net Income | -168.39M |
EBITDA | -131.80M |
EBIT | -132.22M |
Earnings Per Share (EPS) | -$2.00 |
Full Income Statement Balance Sheet
The company has $454.72 million in cash and $1.64 million in debt, giving a net cash position of $453.08 million or $5.30 per share.
Cash & Cash Equivalents | 454.72M |
Total Debt | 1.64M |
Net Cash | 453.08M |
Net Cash Per Share | $5.30 |
Equity (Book Value) | 438.87M |
Book Value Per Share | 5.20 |
Working Capital | 443.75M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -135.50M |
Capital Expenditures | n/a |
Free Cash Flow | -135.50M |
FCF Per Share | -$1.58 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |